Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with <sup>131</sup>I-MIP-1095.

Afshar-Oromieh, Ali; Haberkorn, Uwe; Zechmann, Christian; Armor, Thomas; Mier, Walter; Spohn, Fabian; Debus, Nils; Holland-Letz, Tim; Babich, John; Kratochwil, Clemens

Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with ¹³¹I-MIP-1095.

Afshar-Oromieh, Ali; Haberkorn, Uwe; Zechmann, Christian; Armor, Thomas; Mier, Walter; Spohn, Fabian; Debus, Nils; Holland-Letz, Tim; Babich, John; Kratochwil, Clemens.

Afiliação

Afshar-Oromieh A; Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany. a.afshar@gmx.de.
Haberkorn U; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany. a.afshar@gmx.de.
Zechmann C; Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.
Armor T; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany.
Mier W; Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.
Spohn F; Progenics Pharmaceuticals, Inc., New York, NY, USA.
Debus N; Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.
Holland-Letz T; Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.
Babich J; Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.
Kratochwil C; Department of Biostatistics, German Cancer Research Center, Heidelberg, Germany.

Eur J Nucl Med Mol Imaging ; 44(6): 950-959, 2017 Jun.

Article em En | MEDLINE | ID: mdl-28280855

Assuntos

Antígenos de Superfície/metabolismo; Glutamato Carboxipeptidase II/metabolismo; Glutamatos/metabolismo; Glutamatos/uso terapêutico; Radioisótopos do Iodo/uso terapêutico; Neoplasias de Próstata Resistentes à Castração/metabolismo; Neoplasias de Próstata Resistentes à Castração/radioterapia; Ureia/análogos & derivados; Progressão da Doença; Glutamatos/efeitos adversos; Humanos; Radioisótopos do Iodo/efeitos adversos; Ligantes; Masculino; Metástase Neoplásica; Neoplasias de Próstata Resistentes à Castração/patologia; Estudos Retrospectivos; Segurança; Análise de Sobrevida; Ureia/efeitos adversos; Ureia/metabolismo; Ureia/uso terapêutico

Palavras-chave

Endoradiotherapy; PSMA; Prostate cancer; Prostate-specific membrane antigen

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ureia / Glutamato Carboxipeptidase II / Neoplasias de Próstata Resistentes à Castração / Glutamatos / Radioisótopos do Iodo / Antígenos de Superfície Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google